ONCY
ONCOLYTICS BIOTECH INC · Healthcare
Insiders bought $363K net in the last 90 days ·0 sellers, 10 buyers· latest Form 4 filed Mar 13, 2026
Insider Buying
$363K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Latest filing
Mar 13, 2026
Kelly Jared
ONCOLYTICS BIOTECH INC (ONCY) has 12 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Mar 13, 2026.
Inside the rolling window, 10 insiders at ONCOLYTICS BIOTECH INC reported 14 open-market purchases totaling $363K and no open-market sales. The most active filer is Chief Executive Officer Kelly Jared with 3 filings. Insiders have net bought $363K over the trailing 6 months. The most recent open-market filing is a purchase of 5,050 shares by Chief Executive Officer Kelly Jared, dated Mar 12, 2026, worth $5K.
- Industry:Biotechnology
- CEO:Jared Kelly
- Employees:29
- HQ:San Diego, CA, US
- IPO:2001-10-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Purchase | 5,050 | $5K | Mar 13 | — | SEC ↗ | |
Parsons James T.First filing | Director | Purchase | 10,000 | $10K | Mar 13 | — | SEC ↗ |
| Director | Purchase | 60,000 | $50K | Feb 13 | — | SEC ↗ | |
| Director | Purchase | 40,000 | $34K | Feb 13 | — | SEC ↗ | |
Brown Deborah MargaretFirst filing | Director | Purchase | 25,000 | $21K | Feb 13 | — | SEC ↗ |
Kelly JaredFirst filing | Chief Executive Officer | Purchase | 5,600 | $5K | Feb 13 | — | SEC ↗ |
Kelly JaredFirst filing | Chief Executive Officer | Purchase | 29,500 | $25K | Feb 13 | — | SEC ↗ |
Aromando AndrewFirst filing | Chief Business Officer | Purchase | 29,600 | $25K | Feb 13 | — | SEC ↗ |
Andrews Patricia SFirst filing | Director | Purchase | 35,400 | $30K | Feb 13 | — | SEC ↗ |
Look KirkFirst filing | Chief Financial Officer | Purchase | 12,000 | $10K | Feb 13 | — | SEC ↗ |
| Director | Purchase | 30,000 | $25K | Feb 13 | — | SEC ↗ | |
Hagerman AllisonFirst filing | VP, Product Development | Purchase | 10,000 | $8K | Feb 13 | — | SEC ↗ |
Heineman Thomas CharlesFirst filing | Chief Medical Officer | Purchase | 12,132 | $10K | Feb 13 | — | SEC ↗ |
Seizinger Bernd R.First filing | Director | Purchase | 100,000 | $104K | Jan 20 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ONCY have?
ONCOLYTICS BIOTECH INC (ONCY) has 12 SEC Form 4 filings (14 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Mar 13, 2026.
When was the most recent SEC Form 4 filing for ONCY?
The most recent Form 4 filing for ONCY on Tracefour is dated Mar 13, 2026.
Who is the most active insider at ONCY?
The most active SEC Form 4 filer at ONCY in the rolling window is Chief Executive Officer Kelly Jared, with 3 filings.
What is the net insider flow at ONCY over the last 6 months?
Over the trailing 180 days, insiders at ONCY have net bought $363K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ONCY in the current window?
Inside the rolling window, insiders at ONCY bought $363K and sold $0 based on SEC Form 4 filings.
Can I get alerts for ONCY insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ONCOLYTICS BIOTECH INC (ONCY). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ONCOLYTICS BIOTECH INC is in the Healthcare sector.